Severe Panton-Valentine-Leukocidin-Positive Staphylococcus aureus Infections in Pediatric Age: A Case Report and a

Valeria Garbo1, Laura Venuti1, Giovanni Boncori1

  • 1Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties "G. D'Alessandro", University of Palermo, 90127 Palermo, Italy.

PubMed

Insights

Panton-Valentine leukocidin-producing Staphylococcus aureus (PVL-SA) can cause severe invasive infections in children. Pulmonary involvement significantly predicts the need for intensive care in pediatric PVL-SA cases.

Area of Science:

  • Infectious Diseases
  • Pediatrics
  • Microbiology

Background:

  • Panton-Valentine leukocidin-producing Staphylococcus aureus (PVL-SA) infections are increasingly recognized in community settings.
  • These infections pose significant risks for severe disease in pediatric populations.

Purpose of the Study:

  • To present a pediatric case of invasive PVL-SA disease.
  • To review severe manifestations of PVL-SA in children.
  • To identify predictors for intensive care unit (ICU) admission.

Main Methods:

  • Literature search of PubMed (February 2024) for pediatric PVL-SA cases with clinical outcomes, diagnostics, and treatments.
  • Exclusion of asymptomatic infections and adult cases.
  • Multivariate logistic analysis to determine ICU predictors.

Main Results:

  • A 10-year-old boy presented with necrotizing pneumonia, osteomyelitis, deep vein thrombosis (DVT), and abscesses due to PVL-producing methicillin-resistant Staphylococcus aureus (MRSA).
  • Literature review of 156 pediatric cases revealed high rates of bacteremia (49%), lung infection (47%), and osteomyelitis (37%).
  • Pulmonary involvement was a strong predictor for ICU admission (OR 25.35, p < 0.001).

Conclusions:

  • PVL-SA can cause life-threatening complications in children, including severe pneumonia and sepsis.
  • Pulmonary localization is a critical factor indicating the need for intensive care.
  • Effective therapeutic strategies, including anti-toxin molecules, are crucial for managing severe PVL-SA infections.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
842
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
143
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90